Luigina Graziosi Selected Research

Neoplasm Metastasis (Metastasis)

8/2022	Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
6/2022	Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
12/2021	Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'
1/2020	Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases.
11/2019	Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study.
2/2015	Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection?
1/2012	Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis.
1/2012	Gene expression changes induced by HIPEC in a murine model of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigina Graziosi Research Topics

Disease

17	Stomach Neoplasms (Stomach Cancer) 07/2022 - 06/2011
12	Neoplasms (Cancer) 07/2022 - 03/2011
8	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2012
6	Peritoneal Neoplasms 12/2021 - 01/2012
4	Adenocarcinoma 12/2016 - 03/2011
3	Inflammation (Inflammations) 01/2022 - 12/2017
3	Ascites 01/2016 - 08/2008
2	Colitis 01/2022 - 12/2017
2	Peritoneal Diseases 12/2021 - 12/2013
2	Rectal Neoplasms (Rectal Cancer) 11/2021 - 11/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 12/2017
1	Hemorrhoids 10/2022
1	Wounds and Injuries (Trauma) 10/2022
1	Abscess 10/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Uterine Inertia 06/2016
1	Hemorrhage 06/2016
1	Disseminated Intravascular Coagulation 06/2016
1	False Aneurysm (Pseudoaneurysm) 02/2016
1	Melena 02/2016
1	Abdominal Pain (Pain, Abdominal) 02/2016
1	Fistula 09/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2015
1	Pancreatic Fistula (Pancreatic Fistulas) 09/2015
1	Rectal Prolapse 02/2015
1	Prolapse 02/2015
1	Sepsis (Septicemia) 02/2013
1	Carcinoma (Carcinomatosis) 01/2012
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2012
1	Carcinogenesis 01/2012
1	Cholelithiasis 01/2012
1	Pathologic Constriction (Stenosis) 03/2009
1	Disease Progression 03/2009
1	Mesothelioma 08/2008
1	Necrosis 01/2007

Drug/Important Bio-Agent (IBA)

3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 09/2013
3	Cadherins (E-Cadherin)IBA 01/2016 - 01/2013
2	Capecitabine (Xeloda)FDA Link 09/2020 - 03/2009
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2020 - 03/2011
2	Syk KinaseIBA 12/2017 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2013
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 09/2020
1	Fluorouracil (Carac)FDA LinkGeneric 09/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	RivaroxabanIBA 01/2020
1	sym-trinitrobenzeneIBA 12/2017
1	Dextran SulfateIBA 12/2017
1	Sulfonic AcidsIBA 12/2017
1	Drinking WaterIBA 12/2017
1	Amylases FDA Link 09/2015
1	polyacrylonitrile (Orlon)FDA Link 02/2015
1	Chemokine CCL5IBA 12/2013
1	Maraviroc FDA Link 12/2013
1	Interleukin-10 ReceptorsIBA 12/2013
1	Lymphotoxin-alpha (Lymphotoxin)IBA 12/2013
1	LigandsIBA 12/2013
1	Proto-Oncogene Proteins c-metIBA 12/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 12/2013
1	ElectrolytesIBA 02/2013
1	DiureticsIBA 02/2013
1	Methionine (L-Methionine)FDA Link 01/2013
1	SB 203580IBA 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Mitogen-Activated Protein KinasesIBA 01/2012
1	p38 Mitogen-Activated Protein KinasesIBA 01/2012
1	(4- (5- (4- fluorophenyl)- 2- methylsulfanyl- 3H- imidazol- 4- yl)pyridin- 2- yl)- (1- phenylethyl)amineIBA 01/2012
1	IntegrinsIBA 01/2012
1	Collagen Type IV (Type IV Collagen)IBA 01/2012
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2012
1	ChemokinesIBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2012

Therapy/Procedure

11	Hyperthermic Intraperitoneal Chemotherapy 08/2022 - 08/2008
8	Drug Therapy (Chemotherapy) 12/2021 - 03/2011
7	Cytoreduction Surgical Procedures 08/2022 - 01/2012
6	Therapeutics 10/2022 - 01/2012
4	Gastrectomy 07/2022 - 02/2015
3	Neoadjuvant Therapy 11/2021 - 09/2020
3	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 09/2013
2	Combined Modality Therapy 03/2019 - 02/2015
2	Stents 02/2016 - 03/2009
1	Hemorrhoidectomy 10/2022
1	Radiotherapy 11/2021
1	Enema (Enemas) 12/2017
1	Colectomy 12/2016
1	Hysterectomy 06/2016
1	Palliative Care (Palliative Therapy) 01/2016
1	Pancreatectomy 09/2015
1	Prostheses and Implants (Prosthesis) 02/2015
1	Adjuvant Chemotherapy 02/2015
1	Operative Surgical Procedures 02/2015
1	Laparoscopic Cholecystectomy 01/2012
1	Blood Transfusion (Blood Transfusions) 06/2011
1	Splenectomy 06/2011
1	Enteral Nutrition (Feeding, Tube) 01/2007